A previous meta-analysis involving only 715 cases and 549 controls from 7 studies indicated that serum HE4 is a potential marker for lung cancer diagnosis.[37] Using the previous meta-analysis as a base, we included 3579 samples from 21 studies in our meta-analysis involving 1883 cases and 1696 controls. This evidence concerns the gene WFDC2 and lung carcinoma.